
The global AnimalModelServices market size is predicted to grow from US$ 3525 million in 2025 to US$ 5368 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Animal model services involve the use of live animals in scientific research to simulate human biological processes and disease conditions. These services are crucial in preclinical studies for testing the efficacy and safety of new drugs, therapies, and medical devices before proceeding to human trials. They provide researchers with valuable insights into disease mechanisms, drug interactions, and treatment outcomes, ensuring a controlled and ethical approach to advancing medical science.
鶹ԭ Driver
The animal model services market is primarily driven by the rising demand for preclinical studies in drug discovery and development. With the increasing prevalence of chronic diseases and the need for innovative treatments, pharmaceutical and biotechnology companies rely heavily on animal models to evaluate the efficacy and safety of new therapies. Additionally, advancements in genetic engineering have enabled the creation of more precise animal models that mimic human disease conditions, further fueling market growth.
鶹ԭ Challenge
A significant challenge in the animal model services market is the growing ethical concerns and regulatory restrictions surrounding animal testing. Public awareness and advocacy for animal welfare have led to stricter guidelines, making it imperative for researchers and companies to justify and minimize the use of animal models. Furthermore, the high cost of maintaining facilities and acquiring genetically modified animals poses financial challenges, particularly for smaller research organizations.
鶹ԭ Trend
An emerging trend in the animal model services market is the adoption of alternative and complementary methods to reduce reliance on animal testing. Technologies like organ-on-a-chip, 3D cell cultures, and computer-based simulations are being integrated into research workflows to provide more ethical and cost-effective solutions. Additionally, the development of humanized animal models, which more accurately replicate human biological systems, is gaining traction, aligning with the demand for translational and precision medicine research.
The “AnimalModelServices Industry Forecast” looks at past sales and reviews total world AnimalModelServices sales in 2024, providing a comprehensive analysis by region and market sector of projected AnimalModelServices sales for 2025 through 2031. With AnimalModelServices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AnimalModelServices industry.
This Insight Report provides a comprehensive analysis of the global AnimalModelServices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AnimalModelServices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AnimalModelServices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AnimalModelServices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AnimalModelServices.
This report presents a comprehensive overview, market shares, and growth opportunities of AnimalModelServices market by product type, application, key players and key regions and countries.
Segmentation by Type:
Rats
Mice
Others
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
JANVIER LABS
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 鶹ԭ Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 鶹ԭ Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 鶹ԭ Estimation Caveats
2 Executive Summary
2.1 World 鶹ԭ Overview
2.1.1 Global AnimalModelServices 鶹ԭ Size (2020-2031)
2.1.2 AnimalModelServices 鶹ԭ Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for AnimalModelServices by Country/Region (2020, 2024 & 2031)
2.2 AnimalModelServices Segment by Type
2.2.1 Rats
2.2.2 Mice
2.2.3 Others
2.3 AnimalModelServices 鶹ԭ Size by Type
2.3.1 AnimalModelServices 鶹ԭ Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global AnimalModelServices 鶹ԭ Size 鶹ԭ Share by Type (2020-2025)
2.4 AnimalModelServices Segment by Application
2.4.1 Academic & Research Institutes
2.4.2 Pharmaceutical & Biotechnology Companies
2.5 AnimalModelServices 鶹ԭ Size by Application
2.5.1 AnimalModelServices 鶹ԭ Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global AnimalModelServices 鶹ԭ Size 鶹ԭ Share by Application (2020-2025)
3 AnimalModelServices 鶹ԭ Size by Player
3.1 AnimalModelServices 鶹ԭ Size 鶹ԭ Share by Player
3.1.1 Global AnimalModelServices Revenue by Player (2020-2025)
3.1.2 Global AnimalModelServices Revenue 鶹ԭ Share by Player (2020-2025)
3.2 Global AnimalModelServices Key Players Head office and Products Offered
3.3 鶹ԭ Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AnimalModelServices by Region
4.1 AnimalModelServices 鶹ԭ Size by Region (2020-2025)
4.2 Global AnimalModelServices Annual Revenue by Country/Region (2020-2025)
4.3 Americas AnimalModelServices 鶹ԭ Size Growth (2020-2025)
4.4 APAC AnimalModelServices 鶹ԭ Size Growth (2020-2025)
4.5 Europe AnimalModelServices 鶹ԭ Size Growth (2020-2025)
4.6 Middle East & Africa AnimalModelServices 鶹ԭ Size Growth (2020-2025)
5 Americas
5.1 Americas AnimalModelServices 鶹ԭ Size by Country (2020-2025)
5.2 Americas AnimalModelServices 鶹ԭ Size by Type (2020-2025)
5.3 Americas AnimalModelServices 鶹ԭ Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AnimalModelServices 鶹ԭ Size by Region (2020-2025)
6.2 APAC AnimalModelServices 鶹ԭ Size by Type (2020-2025)
6.3 APAC AnimalModelServices 鶹ԭ Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AnimalModelServices 鶹ԭ Size by Country (2020-2025)
7.2 Europe AnimalModelServices 鶹ԭ Size by Type (2020-2025)
7.3 Europe AnimalModelServices 鶹ԭ Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AnimalModelServices by Region (2020-2025)
8.2 Middle East & Africa AnimalModelServices 鶹ԭ Size by Type (2020-2025)
8.3 Middle East & Africa AnimalModelServices 鶹ԭ Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 鶹ԭ Drivers, Challenges and Trends
9.1 鶹ԭ Drivers & Growth Opportunities
9.2 鶹ԭ Challenges & Risks
9.3 Industry Trends
10 Global AnimalModelServices 鶹ԭ Forecast
10.1 Global AnimalModelServices Forecast by Region (2026-2031)
10.1.1 Global AnimalModelServices Forecast by Region (2026-2031)
10.1.2 Americas AnimalModelServices Forecast
10.1.3 APAC AnimalModelServices Forecast
10.1.4 Europe AnimalModelServices Forecast
10.1.5 Middle East & Africa AnimalModelServices Forecast
10.2 Americas AnimalModelServices Forecast by Country (2026-2031)
10.2.1 United States 鶹ԭ AnimalModelServices Forecast
10.2.2 Canada 鶹ԭ AnimalModelServices Forecast
10.2.3 Mexico 鶹ԭ AnimalModelServices Forecast
10.2.4 Brazil 鶹ԭ AnimalModelServices Forecast
10.3 APAC AnimalModelServices Forecast by Region (2026-2031)
10.3.1 China AnimalModelServices 鶹ԭ Forecast
10.3.2 Japan 鶹ԭ AnimalModelServices Forecast
10.3.3 Korea 鶹ԭ AnimalModelServices Forecast
10.3.4 Southeast Asia 鶹ԭ AnimalModelServices Forecast
10.3.5 India 鶹ԭ AnimalModelServices Forecast
10.3.6 Australia 鶹ԭ AnimalModelServices Forecast
10.4 Europe AnimalModelServices Forecast by Country (2026-2031)
10.4.1 Germany 鶹ԭ AnimalModelServices Forecast
10.4.2 France 鶹ԭ AnimalModelServices Forecast
10.4.3 UK 鶹ԭ AnimalModelServices Forecast
10.4.4 Italy 鶹ԭ AnimalModelServices Forecast
10.4.5 Russia 鶹ԭ AnimalModelServices Forecast
10.5 Middle East & Africa AnimalModelServices Forecast by Region (2026-2031)
10.5.1 Egypt 鶹ԭ AnimalModelServices Forecast
10.5.2 South Africa 鶹ԭ AnimalModelServices Forecast
10.5.3 Israel 鶹ԭ AnimalModelServices Forecast
10.5.4 Turkey 鶹ԭ AnimalModelServices Forecast
10.6 Global AnimalModelServices Forecast by Type (2026-2031)
10.7 Global AnimalModelServices Forecast by Application (2026-2031)
10.7.1 GCC Countries 鶹ԭ AnimalModelServices Forecast
11 Key Players Analysis
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories AnimalModelServices Product Offered
11.1.3 Charles River Laboratories AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 Envigo
11.2.1 Envigo Company Information
11.2.2 Envigo AnimalModelServices Product Offered
11.2.3 Envigo AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.2.4 Envigo Main Business Overview
11.2.5 Envigo Latest Developments
11.3 Taconic Biosciences
11.3.1 Taconic Biosciences Company Information
11.3.2 Taconic Biosciences AnimalModelServices Product Offered
11.3.3 Taconic Biosciences AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.3.4 Taconic Biosciences Main Business Overview
11.3.5 Taconic Biosciences Latest Developments
11.4 Jackson Laboratory
11.4.1 Jackson Laboratory Company Information
11.4.2 Jackson Laboratory AnimalModelServices Product Offered
11.4.3 Jackson Laboratory AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.4.4 Jackson Laboratory Main Business Overview
11.4.5 Jackson Laboratory Latest Developments
11.5 Crown Biosciences
11.5.1 Crown Biosciences Company Information
11.5.2 Crown Biosciences AnimalModelServices Product Offered
11.5.3 Crown Biosciences AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.5.4 Crown Biosciences Main Business Overview
11.5.5 Crown Biosciences Latest Developments
11.6 Shanghai SLAC
11.6.1 Shanghai SLAC Company Information
11.6.2 Shanghai SLAC AnimalModelServices Product Offered
11.6.3 Shanghai SLAC AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.6.4 Shanghai SLAC Main Business Overview
11.6.5 Shanghai SLAC Latest Developments
11.7 Shangghai Modelorg
11.7.1 Shangghai Modelorg Company Information
11.7.2 Shangghai Modelorg AnimalModelServices Product Offered
11.7.3 Shangghai Modelorg AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.7.4 Shangghai Modelorg Main Business Overview
11.7.5 Shangghai Modelorg Latest Developments
11.8 GenOway
11.8.1 GenOway Company Information
11.8.2 GenOway AnimalModelServices Product Offered
11.8.3 GenOway AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.8.4 GenOway Main Business Overview
11.8.5 GenOway Latest Developments
11.9 Syngene International
11.9.1 Syngene International Company Information
11.9.2 Syngene International AnimalModelServices Product Offered
11.9.3 Syngene International AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.9.4 Syngene International Main Business Overview
11.9.5 Syngene International Latest Developments
11.10 Psychogenics
11.10.1 Psychogenics Company Information
11.10.2 Psychogenics AnimalModelServices Product Offered
11.10.3 Psychogenics AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.10.4 Psychogenics Main Business Overview
11.10.5 Psychogenics Latest Developments
11.11 Pharmaron
11.11.1 Pharmaron Company Information
11.11.2 Pharmaron AnimalModelServices Product Offered
11.11.3 Pharmaron AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.11.4 Pharmaron Main Business Overview
11.11.5 Pharmaron Latest Developments
11.12 Pharmalegacy
11.12.1 Pharmalegacy Company Information
11.12.2 Pharmalegacy AnimalModelServices Product Offered
11.12.3 Pharmalegacy AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.12.4 Pharmalegacy Main Business Overview
11.12.5 Pharmalegacy Latest Developments
11.13 Vitalstar Biotechnology
11.13.1 Vitalstar Biotechnology Company Information
11.13.2 Vitalstar Biotechnology AnimalModelServices Product Offered
11.13.3 Vitalstar Biotechnology AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.13.4 Vitalstar Biotechnology Main Business Overview
11.13.5 Vitalstar Biotechnology Latest Developments
11.14 JANVIER LABS
11.14.1 JANVIER LABS Company Information
11.14.2 JANVIER LABS AnimalModelServices Product Offered
11.14.3 JANVIER LABS AnimalModelServices Revenue, Gross Margin and 鶹ԭ Share (2020-2025)
11.14.4 JANVIER LABS Main Business Overview
11.14.5 JANVIER LABS Latest Developments
12 Research Findings and Conclusion
*If Applicable.
